A Proof of Concept Trial of NM 505 in Patients with Type 2 Diabetes
Phase of Trial: Phase I
Latest Information Update: 09 Jun 2015
At a glance
- Drugs NM 505 (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Proof of concept; Therapeutic Use
- 09 Jun 2015 Positive clinical data were presented at the 75th Scientific Sessions of the American Diabetes Association, according to a MicroBiome Therapeutics media release.
- 07 Apr 2015 According to a MicroBiome Therapeutics media release, results of this trial were published in the Journal of Diabetes Science and Technology.
- 16 Feb 2015 New trial record